AMLX vs PEG · rev $87.4M vs P/E 18, rev $10.29B
Amylyx Pharmaceuticals Inc (AMLX) versus Public Service Enterprise Group Inc (PEG) — a side-by-side from cached financials, not a winner call.
Amylyx Pharmaceuticals Inc (AMLX) is a biotechnology company listed on US.
Public Service Enterprise Group Inc (PEG) is a utilities - regulated electric company listed on NYSE.
Latest reported AMLX revenue for 2024-12-31 was $87.4M. Net income was -$301.7M. Revenue was down 77.1% from 2023-12-31 to 2024-12-31. AMLX currently screens at market cap $561.6M.
Latest reported PEG revenue for 2024-12-31 was $10.29B. Net income was $1.77B. Revenue was down 8.4% from 2023-12-31 to 2024-12-31. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
AMLX currently screens at market cap $561.6M. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
Not investment advice. Open the AMLX and PEG stock pages for the full models.
Not investment advice.